Hepatology. 2006 Nov;44(5):1139-45. Hepatitis C virus reinfection in injection drug users. Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW. ...
J Med Virol. 2006 Dec;78(12):1560-3. Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning...
J Med Virol. 2006 Dec;78(12):1688-95. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or Co-infection with hepatitis C, B, and...
J Med Virol. 2006 Dec;78(12):1554-9. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia. Ijaz S, Khulan J, Bissett SL, Ferns RB,...
Hepatology. 2006 Nov;44(5):1122-38. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Honda M, Yamashita...
Journal of Hepatology Volume 45, Issue 5 , November 2006, Pages 636-645 Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated...
From Pharmacotherapy International Adoption: Issues in Infectious Diseases Posted 10/25/2006 Dana D. Staat, Pharm.D.; Michael E. Klepser, Pharm.D., FCCP ...
American College of Gastroenterology 2006 Annual Scientific Meeting and Postgraduate Course Hepatitis B -- What's New and What's on the Horizon? Disclosures ...
AASLD: Drug Lowers Liver Enzyme Levels in Chronic HCV By Neil Osterweil, Senior Associate Editor, MedPage Today Reviewed by Rubeen K. Israni, M.D., Fellow,...
Article Summary New Data for Investigational Hepatitis C Drug Telaprevir (VX-950) to be Pre.. Canada Newswire English - 27-Oct-2006 In addition, clinical...
The American Journal of Gastroenterology Volume 101 Page 2520 - November 2006 doi:10.1111/j.1572-0241.2006.00880.x Volume 101 Issue 11 EDITORIAL Noninvasive...
The American Journal of Gastroenterology Volume 101 Page 2511 - November 2006 doi:10.1111/j.1572-0241.2006.00874.x Volume 101 Issue 11 Platelet Count/Spleen...
The American Journal of Gastroenterology Volume 101 Page 2523 - November 2006 doi:10.1111/j.1572-0241.2006.00812.x Volume 101 Issue 11 Successful Treatment...
Making Headway Against Hepatitis C: New Drug Combo Effective in Non-Responders Posted on: 10/31/2006 Saint Louis University Liver Center scientists are...
The American Journal of Gastroenterology Volume 101 Page 2616 - November 2006 doi:10.1111/j.1572-0241.2006.00909.x Volume 101 Issue 11 EDITORIAL Steatosis in...
The American Journal of Gastroenterology Volume 101 Page 2537 - November 2006 doi:10.1111/j.1572-0241.2006.00788.x Volume 101 Issue 11 Noninvasive Markers of...
Debiopharm Presents New Data Confirming Anti-HCV Activity of Cyclophilin Inhibitor Debio-025 10/31/06 -- The Debiopharm Group (Debiopharm), a global...
The American Journal of Gastroenterology Volume 101 Page 2611 - November 2006 doi:10.1111/j.1572-0241.2006.00918.x Volume 101 Issue 11 Liver Steatosis in...
============================================================ Clinical Care Options for Hepatitis ... Treatment Update With Downloadable Slides Practical...
World J Gastroenterol 2006 November;12(41):6693-6698 Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in...
Baraclude Demonstrated Viral Suppression to Undetectable Levels in Most Patients in a Three-Year Cohort PR Newswire Europe (inc. UK Disclose) - Oct. 30, 2006 ...
ransplant International Volume 19 Page 988 - December 2006 doi:10.1111/j.1432-2277.2006.00377.x Volume 19 Issue 12 ORIGINAL ARTICLE Change in model for...
Hello; This is to let you all know that a Special Edition of the HCV Advocate News Review has now been posted to www.hcvadvocate.org As well, you can catch our...
Elevated ALT Levels Predict Risk of Death From Liver Cancer November 2, 2006 (Boston) — The currently accepted upper limit of normal for serum alanine...
Predictors of Antiretroviral-Related Hepatotoxicity in the Adult AIDS Clinical Trial Group (1989-1999). Brief Report JAIDS Journal of Acquired Immune...